Synthesis, biological evaluation and structural determination of beta-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors
Ahn, J.H., Shin, M.S., Jun, M.A., Jung, S.H., Kang, S.K., Kim, K.R., Rhee, S.D., Kang, N.S., Kim, S.Y., Sohn, S.K., Kim, S.G., Jin, M.S., Lee, J.O., Cheon, H.G., Kim, S.S.(2007) Bioorg Med Chem Lett 17: 2622-2628
- PubMed: 17331715
- DOI: https://doi.org/10.1016/j.bmcl.2007.01.111
- Primary Citation of Related Structures:
2OLE - PubMed Abstract:
Inhibitors of dipeptidyl peptidase IV (DPP-IV) have been shown to be effective treatments for type 2 diabetes. A series of beta-aminoacyl-containing cyclic hydrazine derivatives were synthesized and evaluated as DPP-IV inhibitors. One member of this series, (R)-3-amino-1-(2-benzoyl-1,2-diazepan-1-yl)-4-(2,4,5-trifluorophenyl)butan-1-one (10f), showed potent in vitro activity, good selectivity and in vivo efficacy in mouse models. Also, the binding mode of compound 10f was determined by X-ray crystallography.
Organizational Affiliation:
Bioorganic Science Division, Korea Research Institute of Chemical Technology, Yuseong-Gu, Daejeon 305-600, Republic of Korea. jhahn@krict.re.kr